noscript

News and Announcements

Oncosil Medical Investor Presentation August 2016

  • Published August 22, 2016 10:17AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

22nd August 2016, ASX Announcement

Overview

  • Developing an implantable radiotherapy medical device ‘OncosilTM’ for pancreatic and liver cancer
  • CE Mark targeted in the near term followed by commercial launch and sales in UK, EU and Australia
  • Technology platform suitable for multiple solid state tumours providing a more targeted therapy
  • Global pancreatic cancer market > US1$B
  • Global Pivotal Study underway – FDA approved IDE – July, 2016 Trial sites being engaged
  • New leadership team – Daniel Kenny CEO (ex Baxter, Roche) and Dr Chris Roberts (ex Cochlear CEO) Chairman-elect
  • Proprietary technology with robust patient portfolio
  • ASX listed ~ $69m market cap and $13.4m of cash

Device Overview: Radiation therapy delivered directly into the tumour

  • Pure “soft beta” radiation source (P32) to avoid systemic side effects
  • Localised radiation therapy using “sticky” microparticles
  • Carrier particles are inert silicon
  • Particles are suspended in fluid to allow direct injection into the tumour
  • Single Injection under anesthesia takes 30 minutes
  • Local radiation in the tumour lasts around 3 months

To view the full Presentation, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now